参考文献/References:
[1]Crawford NW,Graham SM.EV71 vaccine:protection from a previously neglected disease[J].Lancet,2013,381(9882):1968-1970.
[2]国家卫生健康委员会.手足口病诊疗指南[J].传染病信息,2018,31(3):193-198.
[3]徐敬,陆敏樱,童琦,等.小儿手足口病的流行病学特征及预防[J].中国卫生标准管理,2015,6(5):16-17.
[4]Li R,Liu L,Mo Z,et al.An inactivated enterovirus 71 vaccine in healthy children[J].N Engl J Med,2014,370(9):829-837.
[5]Yi E,Shin Y,Kim J,et al.Enterovirus 71 infection and vaccines[J].Clin Exp Vaccine Res,2017,6(1):4-14.
[6]高丽,陈爱女,赖耀荣,等.2016年浙江省象山县5岁及以下幼儿家长手足口病认知和EV71疫苗接种意愿调查[J].实用预防医学,2018,25(4):474-477.
[7]李红霞,张文增,陈东妮,等.北京市顺义区5岁以下婴幼儿家长手足口病认知情况与EV71疫苗接种意愿调查[J].公共卫生与预防医学,2016,27(5):25-28.
[8]孙倩莱,高立冬,胡世雄,等.2009-2015年湖南省手足口病死亡病例临床与流行病学特征分析[J].实用预防医学,2017,24(2):148-151.
[9]谢皆强.儿童接种手足口疫苗对手足口病的预防效果及安全性分析[J].中西医结合心血管病杂志,2017,5(36):50,52.
[10]Mao Q,Wang Y,Bian L,et al.EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases[J].Emerg Microbes Infect,2016,20,5(7):e75.
相似文献/References:
[1]覃 艺,邓燕艺,赖昌生,等.手足口病患儿体内免疫球蛋白、补体、C反应蛋白及刺激分析CD80、CD86水平的临床意义及其与丙种球蛋白治疗疗效的关系[J].医学信息,2018,31(02):63.[doi:10.3969/j.issn.1006-1959.2018.02.022]
Qin Yi,DENG Yan-yi,LAI Chang-sheng,et al.Clinical Significance of Immunoglobulin,Complement,C-reactive Protein and CD80,CD86 in Children with Hand-foot-mouth Disease and their Relationship with Therapeutic Effect of Gamma Globulin[J].Journal of Medical Information,2018,31(12):63.[doi:10.3969/j.issn.1006-1959.2018.02.022]
[2]李 淼,孙浩淼,纵书芳,等.徐州地区2015~2016年手足口病流行病学特征分析[J].医学信息,2018,31(02):77.[doi:10.3969/j.issn.1006-1959.2018.02.026]
LI Miao,SUN Hao-miao,ZONG Shu-fang,et al.Epidemiological Characteristics of Hand-foot-mouth Disease in Xuzhou Area in 2015 to 2016[J].Journal of Medical Information,2018,31(12):77.[doi:10.3969/j.issn.1006-1959.2018.02.026]
[3]任燕.手足口病患儿血清淋巴细胞免疫分型的水平变化及临床意义[J].医学信息,2018,31(01):82.[doi:10.3969/j.issn.1006-1959.2018.01.029]
REN Yan.Serum Level of Lymphocyte Immunophenotype in Children with Hand-foot-mouth Disease
and its Clinical Significance[J].Journal of Medical Information,2018,31(12):82.[doi:10.3969/j.issn.1006-1959.2018.01.029]
[4]覃 艺,邓燕艺,赖昌生,等.554例儿童重症手足口病的临床特征分析[J].医学信息,2018,31(11):115.[doi:10.3969/j.issn.1006-1959.2018.11.036]
QIN Yi,DENG Yan-yi,LAI Chang-sheng,et al.Analysis of Clinical Features of Severe Hand Foot and Mouth Disease in 554 Children[J].Journal of Medical Information,2018,31(12):115.[doi:10.3969/j.issn.1006-1959.2018.11.036]
[5]兰文林,白宝鑫,石武祥.手足口病研究进展及防治措施[J].医学信息,2018,31(15):29.[doi:10.3969/j.issn.1006-1959.2018.15.011]
LAN Wen-lin,BAO Bao-xin,SHI Wu-xiang.Research Progress and Control Measures of Hand-Foot-Mouth Disease[J].Journal of Medical Information,2018,31(12):29.[doi:10.3969/j.issn.1006-1959.2018.15.011]
[6]刘 娜,闫卫利.2016年我院儿童病院肠道病毒71型感染情况调查[J].医学信息,2018,31(15):115.[doi:10.3969/j.issn.1006-1959.2018.15.036]
LIU Na,YAN Wei-li.Investigation of Human Enterovirus 71 Infection in our Children's Hospital in 2016[J].Journal of Medical Information,2018,31(12):115.[doi:10.3969/j.issn.1006-1959.2018.15.036]
[7]管 建,姜娟娟.血清IL-6、IL-10、CRP和PCT水平检测对手足口病早期
合并细菌感染患儿的临床诊断价值[J].医学信息,2018,31(15):146.[doi:10.3969/j.issn.1006-1959.2018.15.047]
GUAN Jian,JIANG Juan-juan.Clinical Diagnostic Value of Serum Levels of IL-6,IL-10,CRP and PCT in Children with Hand-Foot-and-Mouth Disease Combined with Early Bacterial Infection[J].Journal of Medical Information,2018,31(12):146.[doi:10.3969/j.issn.1006-1959.2018.15.047]
[8]李正兰.重组人干扰素α1b治疗小儿手足口病的临床疗效观察[J].医学信息,2019,32(05):156.[doi:10.3969/j.issn.1006-1959.2019.05.050]
LI Zheng-lan.Clinical Observation of Recombinant Human Interferon α1b in the Treatment of Hand-Foot-Mouth Disease in Children[J].Journal of Medical Information,2019,32(12):156.[doi:10.3969/j.issn.1006-1959.2019.05.050]
[9]陆志刚,梁 洁,钟 敏.新疆第八师石河子市2015~2018年手足口病原学特征及病流行病学分析[J].医学信息,2019,32(06):82.[doi:10.3969/j.issn.1006-1959.2019.06.026]
LU Zhi-gang,LIANG Jie,ZHONG Min.Epidemiological Characteristics and Epidemiological Analysis of Hand,Foot and Mouth in Shihezi City,the Eighth Division of Xinjiang from 2015 to 2018[J].Journal of Medical Information,2019,32(12):82.[doi:10.3969/j.issn.1006-1959.2019.06.026]
[10]张小华,敏 峰,张玲丽.喜炎平联合单磷酸阿糖腺苷治疗小儿手足口病的
效果及安全性[J].医学信息,2019,32(15):157.[doi:10.3969/j.issn.1006-1959.2019.15.052]
ZHANG Xiao-hua,MIN Feng,ZHANG Ling-li.Application Effect and Safety of Xiyanping Combined with Adenosine Monophosphate in
the Treatment of Hand,Foot and Mouth Disease in Children[J].Journal of Medical Information,2019,32(12):157.[doi:10.3969/j.issn.1006-1959.2019.15.052]